Core Scientific (CORZ) — operating income
Quarterly operating income as filed with the SEC. Each figure below carries the filing it came from, so it can be checked. Most recent: $-78.5M for CY2026Q2, filed 2026-07-28.
| Period | Quarter end | Operating income | Filed | Filing | Restated |
|---|---|---|---|---|---|
| CY2024Q3 | 2024-09-30 | $-41.2M | 2026-03-02 | 10-K/A 0001628280-26-013232 | |
| CY2024Q4 | 2024-12-31 | $-65.4M | 2026-03-02 | 10-K/A 0001628280-26-013232 | |
| CY2025Q1 | 2025-03-31 | $-47.0M | 2026-05-06 | 10-Q 0001628280-26-031396 | |
| CY2025Q2 | 2025-06-30 | $-26.3M | 2026-07-28 | 10-Q 0001839341-26-000014 | |
| CY2025Q3 | 2025-09-30 | $-54.8M | 2026-03-02 | 10-K/A 0001628280-26-013232 | |
| CY2025Q4 | 2025-12-31 | $-117.5M | 2026-03-02 | 10-K/A 0001628280-26-013232 | |
| CY2026Q1 | 2026-03-31 | $-310.4M | 2026-05-06 | 10-Q 0001628280-26-031396 | |
| CY2026Q2 | 2026-06-30 | $-78.5M | 2026-07-28 | 10-Q 0001839341-26-000014 |
Figures are read from the company's own SEC XBRL filings. Nothing is estimated; an unknown is shown as unknown.